Product Decisions This Supports

Enables adoption of mutation testing in CI pipelines by eliminating false positives through static analysis integration
Reduces build time and noise in test reports, improving team velocity and CI efficiency
Avoids custom integration work (build vs buy decision) by leveraging existing static analysis tooling
Supports quality assurance roadmap goals by enforcing analyzer-backed test standards and actionable coverage metrics

When to Consider This Package

Adopt when using Infection with Psalm/PHPStan and experiencing high false positives in mutation test results
When CI pipeline efficiency is hindered by unreliable mutation testing noise or false signals
When enforcing stricter testing standards with measurable, analyzer-validated coverage is a priority
Look elsewhere if mutation testing isn’t part of your workflow, static analysis tools aren’t in use, or the project lacks foundational test coverage

Executives: "This plugin integrates with your existing static analysis tools to cut false positives in mutation testing by up to 50%, saving engineering time and increasing release confidence. It’s a low-cost, high-ROI tool that enhances CI reliability with zero maintenance overhead."
Engineering: "Seamlessly connects Infection with Psalm/PHPStan to automatically filter invalid mutants, ensuring mutation test results are actionable and CI runs faster. Minimal configuration, MIT licensed, and battle-tested in production environments."